Are CRLBF insiders buying or selling?

In the last 90 days, Cresco Labs (CRLBF) had 0 insider transactions. Track every executive trade, dollar amount, and date.

Which hedge funds own CRLBF?

See every hedge fund and asset manager holding Cresco Labs (CRLBF).

How much of CRLBF trades in dark pools?

Track Cresco Labs (CRLBF) dark pool activity and off-exchange block trades.

Cresco Labs (CRLBF) — 47.1% Short — Squeeze Watch

Also trades as: CL.CN (CNQ) · $vol 0M

$0.64

-0.03 (-4.54%)

Pre-Market: $0.65 (+0.01, +1.74%)

Weekly Expected Move ±8.0%

$1 $1 $1 $1 $1

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Sell · Power 27 · $225.9M mcap · 346M float · 0.173% daily turnover · Short 48% of daily vol

Smart Money Score

Watch 0

Insider—

Congress—

ETF Holdings—

Key Statistics

Market Cap$225.9M

52W Range0.535-2.3

Volume180,004

Avg Volume598,769

Beta1.72

Dividend—

Analyst Ratings

4 Buy 3 Hold 0 Sell

Consensus Buy

Company Info

CEOCharles Bachtell

Employees2,900

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

IPO Date2018-12-03

Websitecrescolabs.com

600 W. Fulton Street
Chicago, IL 60661
US

312 929 0993

About Cresco Labs Inc.

Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.

Latest News